Plasma acrolein level and myeloperoxidase gene polymorphism in COPD

M. Ito, M. Hanaoka, Y. Droma, N. Kobayashi, Y. Kitaguchi, Y. Katsuyama, M. Ota, K. Kubo (Matsumoto, Japan)

Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Session: COPD: phenotyping and monitoring
Session type: Thematic Poster Session
Number: 1314
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ito, M. Hanaoka, Y. Droma, N. Kobayashi, Y. Kitaguchi, Y. Katsuyama, M. Ota, K. Kubo (Matsumoto, Japan). Plasma acrolein level and myeloperoxidase gene polymorphism in COPD. Eur Respir J 2010; 36: Suppl. 54, 1314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Associations of an intron MMP9 polymorphism and the serum levels of gelatinase B with the development of COPD
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019


Plasma uteroglobin-related protein 1 (Ugrp1) levels is associated with Ugrp1 -112G/A polymorphism and the severity of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Myeloperoxidase increased in plasma in patients with stable COPD
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

VDBP gene polymorphism in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Correlation of cytokine gene polymorphisms and BALF cytokine levels in ILD
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene)
Source: Eur Respir J 2001; 18: Suppl. 33, 371s
Year: 2001

Association of -308G/A polymorphism of TNF gene with the activity of proteases and antiproteases in sputum in COPD patients
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 585s
Year: 2006

Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma
Source: Eur Respir J, 51 (3) 1701377; 10.1183/13993003.01377-2017
Year: 2018



MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015


Polymorphisms in the interleukin-1 gene cluster correlate with serum total and aeroallergen-specific IgE concentrations in Chinese asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 451s
Year: 2001

Association of 781 C/T interleukin-8 gene polymorphism with asthma and COPD and possible impact on induced sputum inflammatory parameters
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010


A polymorphism -159C/T of CD14 gene regulates the serum soluble CD14 concentration but is not associated with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


IL-13 polymorphism R130Q and total serum IgE levels in children with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 524s
Year: 2002

Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Evaluation of oxidant-antioxidant status in different stages of COPD: determination of serum paraoxonase1 and malonyldialdehyde levels
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF
Source: ERS Lung Science Conference 2021
Year: 2021